1. Enhancing the therapeutic efficacy of Krestin–chitosan nanocomplex for cancer medication via activation of the mitochondrial intrinsic pathway
- Author
-
Albalawi Karma, Panneerselvam Chellasamy, Moawadh Mamdoh S., Alalawy Adel I., Omran Awatif M. E., Abdelaziz Mahmoud A., Mohammedsaleh Zuhair M., Al-Aoh Hatem A., Mustafa Syed Khalid, Keshk Ali A., Al-Morwani Majed M., Alessa Ali Hamzah, Al-Anazi Menier, and Khateeb Sahar
- Subjects
krestin ,breast cancer ,polysaccharide ,chitosan ,apoptotic ,Polymers and polymer manufacture ,TP1080-1185 - Abstract
Surgery, chemotherapy, and radiation therapy are all forms of cancer treatment, as well as more recent methods including interventional radiology and immunotherapy. In this study, we synthesize a novel chitosan (CH) nanocomplex (NC)-based polysaccharide Krestin (PSK) for drug delivery. This technique was used to develop PSK@CH@NC. According to the study, PSK@CH@NC had a particle size of around 500 nm, slight polydispersity as observed under a scanning electron microscope, and a strong positive surface charge of 18 mV. Investigation into the in vitro growth inhibition of the MCF-7 cell line after treatment with CH, PSK, and PSK@CH@NC was followed by morphological changes. Compared to other treatment groups, PSK@CH@NC therapy dramatically reduced the fraction of apoptotic cells, cancer cell survival, and proliferation. Fluorescence analysis was used to examine how PSK@CH@NC affected the distribution of cell cycle phases. This study also shows that a promising foundation for creating cancer nanomedicine can be established by employing new polysaccharides.
- Published
- 2023
- Full Text
- View/download PDF